Cranbrook Wealth Management »

Brainstorm Cell Therapeutics shares owned by Cranbrook Wealth Management

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Cranbrook Wealth Management from 13F filings

Historical chart of Cranbrook Wealth Management investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Cranbrook Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Cranbrook Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $565 1.0k 0.57

More positions owned by Cranbrook Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Intermed Term (BIV)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Eafe Grwth Etf (EFG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Vanguard Index Fds Mcap Vl Idxvip (VOE)

View all positions for Cranbrook Wealth Management

Top funds holding Brainstorm Cell Therapeutics

Vanguard Group
Liberty Wealth Management
Weaver Consulting Group
Caldwell Sutter Capital
Abner, Herrman & BrocK
Raymond James & Associates
GSA Capital Partners
ADAR1 Capital Management
Ikarian Capital
Kingswood Wealth Advisors
Citadel Advisors
Virtu Financial
Jmac Enterprises
Barclays
Wells Fargo & Company

View all funds holding Brainstorm Cell Therapeutics